After finishing at $40.92 in the prior trading day, Baxter International Inc. (NYSE: BAX) closed at $41.01, up 0.22%. In other words, the price has increased by $+0.09 from its previous closing price. On the day, 2824406 shares were traded. BAX stock price reached its highest trading level at $41.21 during the session, while it also had its lowest trading level at $40.27.
Ratios:
Our goal is to gain a better understanding of BAX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.14. For the most recent quarter (mrq), Quick Ratio is recorded 1.04 and its Current Ratio is at 1.48. In the meantime, Its Debt-to-Equity ratio is 1.71 whereas as Long-Term Debt/Eq ratio is at 1.38.
On March 29, 2023, UBS started tracking the stock assigning a Neutral rating and target price of $43.
Morgan Stanley Downgraded its Overweight to Equal-Weight on January 06, 2023, while the target price for the stock was maintained at $55.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 20 when STROUCKEN ALBERT P L sold 3,930 shares for $37.52 per share. The transaction valued at 147,454 led to the insider holds 36,835 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAX now has a Market Capitalization of 20.83B and an Enterprise Value of 32.00B. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.39 while its Price-to-Book (P/B) ratio in mrq is 2.48. Its current Enterprise Value per Revenue stands at 2.16 whereas that against EBITDA is 19.14.
Stock Price History:
Over the past 52 weeks, BAX has reached a high of $50.21, while it has fallen to a 52-week low of $31.01. The 50-Day Moving Average of the stock is 39.67, while the 200-Day Moving Average is calculated to be 39.82.
Shares Statistics:
The stock has traded on average 3.85M shares per day over the past 3-months and 3.69M shares per day over the last 10 days, according to various share statistics. A total of 507.63M shares are outstanding, with a floating share count of 504.85M. Insiders hold about 0.59% of the company’s shares, while institutions hold 91.51% stake in the company. Shares short for BAX as of Feb 15, 2024 were 7.54M with a Short Ratio of 1.96, compared to 9.32M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.48% and a Short% of Float of 1.65%.
Dividends & Splits
In the trailing 12 months, BAX’s forward annual dividend rate was 1.16, compared to 1.16 this year. Against a Trailing Annual Dividend Yield of 2.83%, it implies a Forward Annual Dividend Yield of 2.83%. The stock’s 5-year Average Dividend Yield is 1.66.
Earnings Estimates
Its stock is currently analyzed by 12 different market analysts. On average, analysts expect EPS of $0.61 for the current quarter, with a high estimate of $0.62 and a low estimate of $0.59, while EPS last year was $0.49. The consensus estimate for the next quarter is $0.67, with high estimates of $0.73 and low estimates of $0.63.
Analysts are recommending an EPS of between $2.93 and $2.85 for the fiscal current year, implying an average EPS of $2.89. EPS for the following year is $3.22, with 15 analysts recommending between $3.47 and $3.11.
Revenue Estimates
10 analysts predict $3.55B in revenue for the current quarter. It ranges from a high estimate of $3.59B to a low estimate of $3.53B. As of the current estimate, Baxter International Inc.’s year-ago sales were $3.6B, an estimated decrease of -1.40% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $3.77B, an increase of 1.70% over than the figure of -$1.40% in the same quarter last year. There is a high estimate of $3.79B for the next quarter, whereas the lowest estimate is $3.72B.
A total of 14 analysts have provided revenue estimates for BAX’s current fiscal year. The highest revenue estimate was $15.15B, while the lowest revenue estimate was $15.04B, resulting in an average revenue estimate of $15.1B. In the same quarter a year ago, actual revenue was $14.81B, up 1.90% from the average estimate. Based on 14 analysts’ estimates, the company’s revenue will be $15.65B in the next fiscal year. The high estimate is $15.98B and the low estimate is $15.47B. The average revenue growth estimate for next year is up 3.70% from the average revenue estimate for this year.
